<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Mycobacterial Diseases - High-Yield Board Review By Meshal Bukhari</title>
    <style>
        :root {
            --primary: #2c3e50;
            --secondary: #3498db;
            --accent1: #e74c3c;
            --accent2: #2ecc71;
            --accent3: #f39c12;
            --light: #ecf0f1;
            --dark: #34495e;
            --tt-color: #27ae60;
            --ll-color: #e74c3c;
            --border-color: #bdc3c7;
        }
        
        * {
            box-sizing: border-box;
            margin: 0;
            padding: 0;
        }
        
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            line-height: 1.6;
            color: var(--primary);
            background-color: var(--light);
            padding: 20px;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: white;
            border-radius: 10px;
            box-shadow: 0 5px 15px rgba(0,0,0,0.1);
            overflow: hidden;
        }
        
        header {
            background: var(--primary);
            color: white;
            padding: 20px;
            text-align: center;
            position: relative;
        }
        
        h1 {
            margin-bottom: 10px;
            font-size: 2.2em;
        }
        
        .subtitle {
            font-style: italic;
            font-weight: normal;
            margin-bottom: 20px;
        }
        
        .tabs {
            display: flex;
            background: var(--dark);
        }
        
        .tab-btn {
            flex: 1;
            padding: 15px;
            background: var(--dark);
            color: white;
            border: none;
            cursor: pointer;
            font-size: 16px;
            font-weight: bold;
            transition: all 0.3s;
            border-bottom: 3px solid transparent;
        }
        
        .tab-btn:hover {
            background: var(--primary);
        }
        
        .tab-btn.active {
            background: white;
            color: var(--primary);
            border-bottom: 3px solid var(--secondary);
        }
        
        .tab-content {
            display: none;
            padding: 20px;
        }
        
        .tab-content.active {
            display: block;
        }
        
        h2 {
            color: var(--secondary);
            margin: 20px 0 15px;
            padding-bottom: 5px;
            border-bottom: 2px solid var(--secondary);
        }
        
        h3 {
            color: var(--dark);
            margin: 15px 0 10px;
        }
        
        .memory-box {
            background-color: #f8f9fa;
            border-left: 4px solid var(--accent3);
            padding: 15px;
            margin: 15px 0;
            border-radius: 4px;
        }
        
        .memory-box h4 {
            color: var(--accent3);
            margin-bottom: 10px;
        }
        
        .spectrum-container {
            display: flex;
            margin: 20px 0;
            border: 1px solid var(--border-color);
            border-radius: 8px;
            overflow: hidden;
        }
        
        .spectrum-side {
            flex: 1;
            padding: 15px;
        }
        
        .tt-side {
            background-color: rgba(39, 174, 96, 0.1);
            border-right: 1px solid var(--border-color);
        }
        
        .ll-side {
            background-color: rgba(231, 76, 60, 0.1);
        }
        
        .spectrum-header {
            text-align: center;
            font-weight: bold;
            padding: 10px;
            margin-bottom: 10px;
            border-radius: 5px;
        }
        
        .tt-header {
            background-color: var(--tt-color);
            color: white;
        }
        
        .ll-header {
            background-color: var(--ll-color);
            color: white;
        }
        
        .table-container {
            overflow-x: auto;
            margin: 20px 0;
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 15px 0;
        }
        
        th, td {
            border: 1px solid var(--border-color);
            padding: 10px;
            text-align: left;
        }
        
        th {
            background-color: var(--secondary);
            color: white;
        }
        
        tr:nth-child(even) {
            background-color: #f2f2f2;
        }
        
        .card-container {
            display: flex;
            flex-wrap: wrap;
            justify-content: space-between;
            margin: 20px 0;
        }
        
        .card {
            width: 48%;
            margin-bottom: 20px;
            background: white;
            border-radius: 8px;
            box-shadow: 0 2px 5px rgba(0,0,0,0.1);
            overflow: hidden;
        }
        
        .card-header {
            padding: 10px 15px;
            font-weight: bold;
            color: white;
        }
        
        .card-body {
            padding: 15px;
        }
        
        .type1-header {
            background-color: var(--accent2);
        }
        
        .type2-header {
            background-color: var(--accent1);
        }
        
        .drug-header {
            background-color: var(--accent3);
        }
        
        .collapsible {
            background-color: #f9f9f9;
            color: var(--primary);
            cursor: pointer;
            padding: 15px;
            width: 100%;
            border: none;
            text-align: left;
            outline: none;
            font-size: 16px;
            font-weight: bold;
            margin-top: 10px;
            border-radius: 4px;
            display: flex;
            justify-content: space-between;
            align-items: center;
            transition: 0.3s;
        }
        
        .collapsible:hover {
            background-color: #eee;
        }
        
        .collapsible:after {
            content: '\002B';
            color: var(--primary);
            font-weight: bold;
            float: right;
            margin-left: 5px;
        }
        
        .collapsible.active:after {
            content: "\2212";
        }
        
        .content {
            padding: 0 15px;
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.2s ease-out;
            background-color: white;
            border-radius: 0 0 4px 4px;
        }
        
        .content-inner {
            padding: 15px 0;
        }
        
        ul, ol {
            padding-left: 20px;
            margin: 10px 0;
        }
        
        li {
            margin-bottom: 5px;
        }
        
        .highlight {
            background-color: #ffffcc;
            padding: 2px 4px;
            border-radius: 3px;
        }
        
        .drug-table th:first-child {
            width: 20%;
        }
        
        .drug-table th {
            text-align: center;
        }
        
        /* Search feature styling */
        .search-container {
            display: flex;
            margin: 15px auto 0;
            max-width: 500px;
            position: relative;
        }
        
        #searchInput {
            width: 100%;
            padding: 12px 20px;
            border: none;
            border-radius: 25px;
            background-color: rgba(255, 255, 255, 0.9);
            font-size: 16px;
            transition: all 0.3s;
            box-shadow: 0 2px 5px rgba(0,0,0,0.2);
        }
        
        #searchInput:focus {
            outline: none;
            box-shadow: 0 4px 10px rgba(0,0,0,0.3);
            background-color: white;
        }
        
        #searchButton {
            position: absolute;
            right: 10px;
            top: 50%;
            transform: translateY(-50%);
            background: transparent;
            border: none;
            cursor: pointer;
            color: var(--secondary);
            font-size: 18px;
        }
        
        .search-results-container {
            display: none;
            position: absolute;
            top: 100%;
            left: 50%;
            transform: translateX(-50%);
            width: 90%;
            max-width: 800px;
            max-height: 400px;
            background: white;
            border-radius: 10px;
            box-shadow: 0 5px 15px rgba(0,0,0,0.2);
            margin-top: 10px;
            z-index: 1000;
            overflow: hidden;
        }
        
        .search-results-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            padding: 10px 15px;
            background: var(--secondary);
            color: white;
            font-weight: bold;
        }
        
        #closeResults {
            background: transparent;
            border: none;
            color: white;
            cursor: pointer;
            font-size: 16px;
        }
        
        .results-list {
            overflow-y: auto;
            max-height: 350px;
            padding: 10px;
        }
        
        .result-item {
            padding: 10px;
            border-bottom: 1px solid #eee;
            cursor: pointer;
            transition: background-color 0.2s;
        }
        
        .result-item:hover {
            background-color: #f9f9f9;
        }
        
        .result-item h4 {
            margin: 0 0 5px;
            color: var(--primary);
        }
        
        .result-context {
            font-size: 14px;
            color: #666;
            white-space: nowrap;
            overflow: hidden;
            text-overflow: ellipsis;
        }
        
        .search-highlight {
            background-color: #ffeb3b;
            padding: 2px 0;
            border-radius: 2px;
            font-weight: bold;
        }
        
        /* For responsiveness */
        @media (max-width: 768px) {
            .search-container {
                max-width: 90%;
            }
            
            .search-results-container {
                width: 95%;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <header>
            <h1>Mycobacterial Diseases</h1>
            <div class="subtitle">High-Yield Board Review</div>
            <!-- Add search container -->
            <div class="search-container">
                <input type="text" id="searchInput" placeholder="Search for a term..." aria-label="Search box">
                <button id="searchButton"><i class="fas fa-search"></i></button>
            </div>
            <!-- Add results container -->
            <div id="searchResults" class="search-results-container">
                <div class="search-results-header">
                    <span id="resultCount">0 results</span>
                    <button id="closeResults"><i class="fas fa-times"></i></button>
                </div>
                <div id="resultsList" class="results-list"></div>
            </div>
        </header>
        
        <div class="tabs">
            <button class="tab-btn active" onclick="openTab(event, 'leprosy')">Leprosy</button>
            <button class="tab-btn" onclick="openTab(event, 'cutaneous-tb')">Cutaneous TB</button>
            <button class="tab-btn" onclick="openTab(event, 'ntm')">NTM</button>
            <button class="tab-btn" onclick="openTab(event, 'tb-drugs')">TB Drug Side Effects</button>
        </div>
        
        <!-- LEPROSY TAB -->
        <div id="leprosy" class="tab-content active">
            <h2>Leprosy (Hansen's Disease)</h2>
            
            <div class="memory-box">
                <h4>üß† Memory Hooks</h4>
                <ul>
                    <li><strong>DR for TT</strong>: HLA-DR2 & HLA-DR3 associated with Tuberculoid Leprosy</li>
                    <li><strong>DQ for LL</strong>: HLA-DQ1 associated with Lepromatous Leprosy</li>
                    <li><strong>RD for PB</strong>: Rifampin + Dapsone for Paucibacillary Leprosy</li>
                    <li><strong>RDC for MB</strong>: Rifampin + Dapsone + Clofazimine for Multibacillary</li>
                    <li><strong>Th1 for TT</strong>: Strong Th1 response in Tuberculoid</li>
                    <li><strong>Th2 for LL</strong>: Stronger Th2 response in Lepromatous</li>
                </ul>
            </div>
            
            <h3>Classification & Immunology: The Spectrum</h3>
            
            <div class="spectrum-container">
                <div class="spectrum-side tt-side">
                    <div class="spectrum-header tt-header">TT (Tuberculoid) Pole</div>
                    <ul>
                        <li>Strong Cell-Mediated Immunity (CMI)</li>
                        <li>Robust Th1 response</li>
                        <li>Granulomas++</li>
                        <li>Few bacilli (paucibacillary)</li>
                        <li>Positive lepromin test (Mitsuda reaction)</li>
                        <li>HLA-DR2 & HLA-DR3 association</li>
                    </ul>
                </div>
                <div class="spectrum-side ll-side">
                    <div class="spectrum-header ll-header">LL (Lepromatous) Pole</div>
                    <ul>
                        <li>Weak Cell-Mediated Immunity</li>
                        <li>Th2 humoral response predominates</li>
                        <li>Lots of bacilli in macrophages (Virchow cells)</li>
                        <li>Negative lepromin test</li>
                        <li>HLA-DQ1 association</li>
                    </ul>
                </div>
            </div>
            
            <button class="collapsible">Borderline Forms (BT, BB, BL)</button>
            <div class="content">
                <div class="content-inner">
                    <p>These are the in-between stages, reflecting varying levels of immunity:</p>
                    <ul>
                        <li><strong>BT</strong>: Closer to TT pole</li>
                        <li><strong>BB</strong>: Middle of spectrum ("borderline borderline")</li>
                        <li><strong>BL</strong>: Closer to LL pole</li>
                    </ul>
                </div>
            </div>
            <button class="collapsible">Clinical Features</button>
            <div class="content">
                <div class="content-inner">
                    <div class="table-container">
                        <table>
                            <tr>
                                <th>Clinical Findings</th>
                                <th style="background-color: var(--ll-color);">Lepromatous (LL)</th>
                                <th style="background-color: var(--tt-color);">Tuberculoid (TT)</th>
                            </tr>
                            <tr>
                                <td><strong>Type of lesions</strong></td>
                                <td>Small hypopigmented macules, papulonodules, and <span class="highlight">diffuse infiltration</span> (‚Üí <span class="highlight">leonine facies</span>, elongated earlobes, and madarosis). Loss of eyebrows.</td>
                                <td><span class="highlight">Dry, scaly, hypopigmented, and anesthetic plaques</span> with raised peripheral rim and central atrophy +/- <span class="highlight">alopecia</span> and anhidrosis</td>
                            </tr>
                            <tr>
                                <td><strong>Lesion number/size</strong></td>
                                <td><span class="highlight">Innumerable, small</span></td>
                                <td><span class="highlight">One or few</span> (<5); large</td>
                            </tr>
                            <tr>
                                <td><strong>Distribution</strong></td>
                                <td><span class="highlight">Widespread</span></td>
                                <td><span class="highlight">Localized, asymmetric</span></td>
                            </tr>
                            <tr>
                                <td><strong>Circumscription</strong></td>
                                <td><span class="highlight">Poorly defined</span> lesions and difficult to discern edges</td>
                                <td><span class="highlight">Well-defined</span>; sharply demarcated raised/indurated borders</td>
                            </tr>
                            <tr>
                                <td><strong>Sensation within lesions</strong></td>
                                <td><span class="highlight">Normal</span></td>
                                <td><span class="highlight">Absent</span></td>
                            </tr>
                            <tr>
                                <td><strong>Site of nerve enlargement</strong></td>
                                <td>Symmetric and <span class="highlight">not a/w skin lesions</span></td>
                                <td>Asymmetric and <span class="highlight">localized around skin lesions</span></td>
                            </tr>
                            <tr>
                                <td><strong>Lepromin test</strong></td>
                                <td><span class="highlight">Negative</span></td>
                                <td><span class="highlight">+++</span></td>
                            </tr>
                            <tr>
                                <td><strong>Cell-mediated immunity</strong></td>
                                <td>None<br>(<span class="highlight">Th2 >> Th1</span>)</td>
                                <td>Strong<br>(<span class="highlight">Th1 >> Th2</span>)</td>
                            </tr>
                            <tr>
                                <td><strong>Bacilli in skin lesions</strong></td>
                                <td><span class="highlight">++++ (globi)</span></td>
                                <td><span class="highlight">None</span></td>
                            </tr>
                            <tr>
                                <td><strong>AFB stain</strong><br>(Fite-Faraco stain is best)</td>
                                <td><span class="highlight">++++</span></td>
                                <td><span class="highlight">Negative</span></td>
                            </tr>
                            <tr>
                                <td><strong>Histology</strong></td>
                                <td><span class="highlight">Grenz zone</span>, diffuse infiltrate of <span class="highlight">parasitized foamy histiocytes (Virchow cells)</span>, free-floating <span class="highlight">clumps of bacilli (globi)</span> in dermis, and "onion-skin" pattern around nerves; lacks well-formed granulomas</td>
                                <td>Well-formed sarcoidal <span class="highlight">granulomas w/linear arrangement (East-West) along nerves</span>, numerous Langhans giant cells, fragmented nerve fibers, <span class="highlight">lacks organisms</span> (no globi or Virchow cells), and Grenz zone</td>
                            </tr>
                            <tr>
                                <td><strong>Associated findings</strong></td>
                                <td>Acquired ichthyosis, <span class="highlight">madarosis, saddle nose</span>, lagophthalmos, and orchitis (‚Üí sterility and gynecomastia)</td>
                                <td>Alopecia<br>Anhidrosis</td>
                            </tr>
                            <tr>
                                <td><strong>Other comments</strong></td>
                                <td><span class="highlight">High risk for type 2 reaction</span><br>Lesions do not have anhidrosis or alopecia</td>
                                <td>Skin lesions favor face, extremities, and cool areas of trunk<br><span class="highlight">TT often self resolves in 3 years</span></td>
                            </tr>
                        </table>
                    </div>
                </div>
            </div>

            
            <button class="collapsible">Peripheral Nerve Involvement</button>
            <div class="content">
                <div class="content-inner">
                    <p><strong>Thickened Nerves</strong> - Key sites to remember:</p>
                    <ul>
                        <li>Facial nerve (CN7) and trigeminal nerve (CN5)</li>
                        <li>Ulnar nerve at the elbow</li>
                        <li>Common peroneal nerve at fibular head</li>
                        <li>Greater auricular nerve in neck</li>
                        <li>Posterior tibial nerve behind medial malleolus</li>
                    </ul>
                    <p>Results in sensory and motor deficits along nerve distribution.</p>
                </div>
            </div>
            
            <button class="collapsible">Work-up</button>
            <div class="content">
                <div class="content-inner">
                    <div class="memory-box">
                        <h4>üß† Diagnostic Methods</h4>
                        <ul>
                            <li><strong>Skin biopsy</strong> from active margins
                                <ul>
                                    <li><span class="highlight">Stains:</span> Gram, Ziehl-Neelsen, or <strong>Fite</strong> (most commonly used) ‚Üí stain bright red color</li>
                                    <li>Methenamine silver ‚Üí fragmented acid-fast bacilli</li>
                                    <li>Sudan III and Sudan IV (historically) ‚Üí stain bacilli black and red</li>
                                    <li><span class="highlight">At least six sections</span> must be examined before declaring samples negative</li>
                                </ul>
                            </li>
                            <li><strong>Scrapings</strong> of skin, lymph nodes, or nasal secretions</li>
                            <li><strong>Bacilloscopy</strong>
                                <ul>
                                    <li>Obtain sample ‚Üí smear and stain ‚Üí search for red rods (against a blue background)</li>
                                    <li>Examined at 100√ó with oil immersion</li>
                                </ul>
                            </li>
                            <li><strong>Organism prevalence</strong>
                                <ul>
                                    <li><span class="highlight">100% of LL</span> ‚Ä¢ 75% of BL ‚Ä¢ 5% of TL</li>
                                </ul>
                            </li>
                            <li><strong>PCR</strong> ‚Üí useful for paucibacillary cases
                                <ul>
                                    <li>Performed on slit-skin smears and fresh, frozen, or paraffin-embedded skin biopsy specimens</li>
                                </ul>
                            </li>
                            <li><strong>IHC</strong>
                                <ul>
                                    <li>+ve staining for the <span class="highlight">PGL-1 antigen</span> in paucibacillary disease</li>
                                </ul>
                            </li>
                            <li><strong>Serology w/ Anti-PGL Abs (IgG and IgM)</strong> ‚Üí for multibacillary cases
                                <ul>
                                    <li>Classify patients, monitor response to treatment, and predict reactions</li>
                                    <li>A marker of mycobacterial "load"</li>
                                    <li><span class="highlight">Elevation of anti-PGL IgM antibody levels</span> is associated with reactions and impairment of nerve function</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </div>
            </div>
            
            <button class="collapsible">Treatment (WHO recommendations)</button>
            <div class="content">
                <div class="content-inner">
                    <div class="memory-box">
                        <p><span class="highlight">Importantly, after the first dose, the patient is no longer infectious to others</span></p>
                        <table class="treatment-table">
                            <thead>
                                <tr>
                                    <th>Classification</th>
                                    <th>Clinical Features</th>
                                    <th>Duration</th>
                                    <th>Treatment Regimen</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td><span class="highlight">Multibacillary</span></td>
                                    <td>>5 skin lesions</td>
                                    <td>12-18 months</td>
                                    <td><span class="highlight">rifampicin 600 mg Qmonth + dapsone 100 mg QD + clofazimine 300 mg once a month and 50 mg daily</span></td>
                                </tr>
                                <tr>
                                    <td><span class="highlight">Paucibacillary</span></td>
                                    <td>2-5 skin lesions</td>
                                    <td>6 -9 months</td>
                                    <td><span class="highlight">rifampicin 600 mg Qmonth + dapsone 100 mg QD</span></td>
                                </tr>
                                <tr>
                                    <td>Single skin lesion paucibacillary</td>
                                    <td>1 skin lesion</td>
                                    <td><span class="highlight">single dose</span></td>
                                    <td><span class="highlight">rifampicin 600 mg + ofloxacin 400 mg + minocycline 100 mg</span></td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                    
                    <h3>Pediatric Dosing</h3>
                    <div class="memory-box">
                        <table class="treatment-table">
                            <thead>
                                <tr>
                                    <th>Patient Category</th>
                                    <th>Rifampicin</th>
                                    <th>Clofazimine</th>
                                    <th>Dapsone</th>
                                    <th>Ofloxacin</th>
                                    <th>Minocycline</th>
                                    <th>Duration</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>10 to 14 years of age, MB</td>
                                    <td>450 mg once monthly</td>
                                    <td>150 mg once monthly and 50 mg every other day</td>
                                    <td>50 mg daily</td>
                                    <td>-</td>
                                    <td>-</td>
                                    <td>12 blister packs over 12 to 18 months</td>
                                </tr>
                                <tr>
                                    <td>&lt;10 years of age, MB</td>
                                    <td>300 mg once monthly</td>
                                    <td>100 mg once monthly and 50 mg twice weekly</td>
                                    <td>25 mg daily</td>
                                    <td>-</td>
                                    <td>-</td>
                                    <td>12 blister packs over 12 to 18 months</td>
                                </tr>
                                <tr>
                                    <td>5 to 14 years of age, single lesion PB</td>
                                    <td>300 mg √ó 1</td>
                                    <td>-</td>
                                    <td>-</td>
                                    <td>200 mg √ó 1</td>
                                    <td>50 mg √ó 1</td>
                                    <td>Single dose</td>
                                </tr>
                            </tbody>
                        </table>
                        <p><small>‚Ä†For PB disease (2‚Äì5 lesions), clofazimine is not required and the duration of therapy is 6 to 9 months.</small></p>
                    </div>
                    
                    <div class="memory-box">
                        <h4>üìå Household Contact Risk</h4>
                        <ul>
                            <li><span class="highlight" style="background-color: orange; color: rgb(0, 0, 0);">~20-25% increased risk for household contacts</span></li>
                            <li>WHO recommends single-dose Rifampin prophylaxis in endemic areas</li>
                        </ul>
                    </div>
                </div>
            </div>


                 
            
            <h3>Leprosy Reactions</h3>
            
            <div class="card-container">
                <div class="card">
                    <div class="card-header type1-header">Type 1 Reaction (Reversal)</div>
                    <div class="card-body">
                       
                        <ul>
                            <li><strong>Immunology:</strong> <span class="highlight">Increased Th1 response. In Borderline Types</span></li>
                            <li><strong>Timing:</strong> Before(in case of pregnancy , Stress , or other infections), during, or after treatment</li>
                            <li><strong>Clinical:</strong> Existing lesions become inflamed, edematous and ulcerated</li>
                            <li><strong>Neuritis:</strong> Common - nerve pain, tenderness</li>
                            <li><strong>Systemic:</strong> None, unlike Type 2</li>
                            <li><strong>Management:</strong> <span class="highlight">Prednisone: 40 mg per
                                day tapered over 12 to
                                36 weeks, depending upon whether paucibacillary vs multibacillary</span></li>
                        </ul>
                    </div>
                </div>
                
                <div class="card">
                    <div class="card-header type2-header">Type 2 Reaction (ENL)</div>
                    <div class="card-body">
                        <p><strong>Think:</strong> Immune Complex Deposition, in lepromatous</p>
                        <ul>
                            <li><strong>Immunology:</strong> Th2 response, immune complex formation</li>
                            <li><strong>Timing:</strong> Common in LL and BL during MB treatment</li>
                            <li><strong>Clinical:</strong> New painful erythematous nodules</li>
                            <li><strong>Systemic:</strong> Fever, malaise, neuritis, iridocyclitis</li>
                            <li><strong>Management:</strong> <span class="highlight">Thalidomide: for severe
                                disease, 400 mg po daily then taper to 300 mg
                                po daily once reaction under control followed by taper to the lowest dose without a flare; latter
                                dose then continued 2‚Äì3 months</span> </li>
                        </ul>
                    </div>
                </div>
                <div class="card">
                    <div class="card-header type2-header">Lucio Phenomenon</div>
                    <div class="card-body">
                        <p><strong>Think:</strong> Severe Necrotizing Vasculitis, in lepromatous</p>
                        <ul>
                            <li><strong>Epidemiology:</strong> Only occurs in patients from western Mexico</li>
                            <li><strong>Association:</strong> Diffuse lepromatous leprosy</li>
                            <li><strong>Pathology:</strong> Necrotizing vasculitis with thrombosis</li>
                            <li><strong>Clinical:</strong> Purpuric macules and ulcerative bullous lesions below the knees</li>
                            <li><strong>Management:</strong> <span class="highlight">Prednisone</span></li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        
        <!-- CUTANEOUS TB TAB -->
        <div id="cutaneous-tb" class="tab-content">
            <h2>Cutaneous Tuberculosis</h2>
            
            <div class="memory-box">
                <h4>üß† Classification by Route</h4>
                <ul>
                    <li><strong>Endogenous:</strong> Lupus Vulgaris üõ°Ô∏è, Scrofuloderma, Orificial tuberculosis, acute miliary tuberculosis, Tuberculous gumma </li>
                    <li><strong> Inoculation:</strong> Tuberculous Chancre in TB na√Øve individuals (wtihout previous Immunity), TBVC - "Warty TB" üõ°Ô∏è - direct inoculation in previously exposed (with previous Immunity)</li>
                    <li><strong>Tuberculids:</strong> Papulonecrotic tuberculid üõ°Ô∏è, Lichen scrofulosorum üõ°Ô∏è, Erythema induratum üõ°Ô∏è</li>
                    <li><strong>BCG Inoculation:</strong> Complications from BCG vaccination include localized or generalized tuberculids, lupus vulgaris, scrofuloderma, and nonspecific reactions (fever, inflammation, abscesses). Rarely causes disseminated infection in immunodeficient patients affecting the IL-12/IFN-Œ≥ axis. MER (methanol extraction residue) of BCG used in melanoma immunotherapy can cause nodules and subcutaneous abscesses.</li>
                </ul>
            </div>
            
            <h3>Clinical Presentations</h3>
            
            <button class="collapsible">Lupus Vulgaris (LV)</button>
            <div class="content">
                <div class="content-inner">
                    <ul>
                        <li>Chronic progressive. Contiguous spread , hematogenously or via lymphatics</li>
                        <li><span class="highlight">"Apple Jelly" </span> (hallmark) - seen on diascopy</li>
                        <li>Red-brown, sometimes annular papules/plaques</li>
                        <li>Multiple clinical presentations:
                            <ul>
                                <li>Plaque-type</li>
                                <li>Ulcerative or mutilating</li>
                                <li>Vegetating</li>
                                <li>Tumor-like</li>
                                <li>Papulonodular</li>
                            </ul>
                        </li>
                        <li>Head and neck predilection (especially face, nose, ears, cheeks)</li>
                        <li>Scarring centrally as it heals</li>
                        <li>Associated with moderate to high immunity</li>
                        <li>Skin test: Usually positive</li>
                        <li>Histopathology: No bacilli present</li>
                    
                        <li><img src="images/Vu2.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                        <li><img src="images/Vu3.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                        <li><img src="images/Vu4.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                        <li><img src="images/Vu5.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                        <li><img src="images/Vu6.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                        <li><img src="images/Vu7.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                        <li><img src="images/Vu8.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                        <li><img src="images/Vu9.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                        <li><img src="images/Vulgaris.jpg"  style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                    </ul>
                </div>
            </div>
            
            <button class="collapsible">Scrofuloderma ("King's Evil")</button>
            <div class="content">
                <div class="content-inner">
                    <ul>
                        <li><span class="highlight">"Cold Abscess"</span> - firm subcutaneous nodule becoming fluctuant</li>
                        <li>Multiple draining sinuses</li>
                        <li>spread from underlying infected nodes/bone (usually cervical)</li>
                        <li>Keloid scarring after healing</li>
                        <li>Associated with low immunity</li>
                        <li>Often seen in cervical, axillary, or inguinal regions</li>
                        <li>Can lead to significant disfigurement if untreated</li>
                        <li><img src="images/Scrofulderma.jpg" alt="Cutaneous tuberculosis presenting as a characteristic ulcerative lesion" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                    </ul>
                </div>
            </div>
            <button class="collapsible">Orificial Tuberculosis</button>
            <div class="content">
                <div class="content-inner">
                    <ul>
                        <li><span class="highlight">Painful ulcers at orifices</span> - marker of severe systemic TB</li>
                        <li>Results from autoinoculation from active internal TB focus (pulmonary, intestinal, anogenital)</li>
                        <li>Most common location: mouth, especially tongue</li>
                        <li>Starts as edematous red papule that progresses to painful ulcer with undermined edges</li>
                        <li>Associated with compromised immunity and advanced disease</li>
                        <li>Tuberculin test: Often variable or negative (reflecting immune compromise)</li>
                        <li>Histopathology: Nonspecific
                            inflammatory infiltrate and
                            necrosis, some tubercles with caseation deep in dermis;
                            bacilli easily found</li>
                        <li>Diagnosis requires:
                            <ul>
                                <li>Clinical suspicion in patients with non-healing orificial ulcers</li>
                                <li>Histology and culture for confirmation</li>
                                <li>Investigation for underlying systemic TB (essential)</li>
                                <li>PCR for rapid diagnosis</li>
                            </ul>
                        </li>
                        <li>Differential diagnosis: HSV, aphthous ulcers, pemphigus, histoplasmosis</li>
                        <li>Treatment focuses on standard antituberculous therapy for underlying systemic disease</li>
                        <li><img src="images/oro.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                        <li><img src="images/oro1.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                    </ul>
                </div>
            </div>

            <button class="collapsible">Acute Miliary Tuberculosis</button>
            <div class="content">
                <div class="content-inner">
                    <ul>
                        <li><span class="highlight">Pinhead-sized, bluish-red papules capped by minute vesicles</span> - marker of disseminated TB</li>
                        <li>Also known as: Tuberculosis cutis disseminata, Tuberculosis cutis acuta generalisata</li>
                        <li>Vesicles develop central umbilication followed by crusting</li>
                        <li>Healing leaves white scars with brownish rim</li>
                        <li>Results from hematogenous dissemination during bacillemia</li>
                        <li>Typically occurs in:
                            <ul>
                                <li>Children with low socioeconomic status</li>
                                <li>Immunocompromised hosts</li>
                                <li>May follow viral infection</li>
                            </ul>
                        </li>
                        <li>Tuberculin test: Usually negative (reflecting immune compromise)</li>
                        <li>Histopathology: Prominent necrosis with nonspecific inflammatory infiltrate; abundant bacilli in tissue sections</li>
                        <li>Diagnosis requires:
                            <ul>
                                <li>Smear, histology, and culture of skin lesions</li>
                                <li>PCR for rapid detection</li>
                                <li>Investigation for primary TB focus (usually lungs)</li>
                            </ul>
                        </li>
                        <li>Differential diagnosis: Varicella, enteroviral exanthems, rickettsialpox, PLEVA</li>
                        <li>Treatment focuses on standard antituberculous therapy for underlying systemic disease</li>
                    </ul>
                </div>
            </div>

            <button class="collapsible">Tuberculous Gumma</button>
            <div class="content">
                <div class="content-inner">
                    <ul>
                        <li>Also known as: Metastatic tuberculous ulcer, Metastatic tuberculous abscess</li>
                        <li><span class="highlight">Firm subcutaneous nodule that slowly softens, forming undermined ulcers and sinus tracts</span></li>
                        <li>Results from hematogenous spread (mycobacteremia with cutaneous seeding)</li>
                        <li>Typically affects extremities (lower) </li>
                        <li>Typically occurs in:
                            <ul>
                                <li>Children with low socioeconomic status</li>
                                <li>Immunocompromised hosts</li>
                            </ul>
                        </li>
                        <li>Tuberculin test: Usually negative (reflecting immune compromise)</li>
                        <li>Histopathology: Massive necrosis and abscess formation; abundant bacilli in necrotic tissue</li>
                        <li>Diagnosis requires:
                            <ul>
                                <li>Culture and histology of lesions</li>
                                <li>PCR for rapid identification</li>
                                <li>Investigation for other TB foci</li>
                                <li>IGRA may be indeterminate, especially in immunocompromised patients</li>
                            </ul>
                        </li>
                        <li>Differential diagnosis: Panniculitis, dimorphic/opportunistic fungal infections, syphilitic gumma, hidradenitis suppurativa</li>
                        <li>Treatment focuses on standard antituberculous therapy with local wound care; surgical drainage may be considered</li>
                    </ul>
                </div>
            </div>
            <button class="collapsible">TB Verrucosa Cutis (TBVC)</button>
            <div class="content">
                <div class="content-inner">
                    <ul>
                        <li>Most common form of cutaneous tuberculosis </li>
                        <li>Occurs in previously infected persons with moderate to high immunity to M. tuberculosis</li>
                        <li>Results from exogenous inoculation at trauma-prone sites</li>
                        <li>Typically affects extremities (hands, feet) at sites of trauma</li>
                        <li>Common in occupational exposure (pathologists, butchers)</li>
                        <li>Clinical features:
                            <ul>
                                <li>Begins as small, asymptomatic, indurated wart-like papule with inflammatory rim</li>
                                <li>Gradually enlarges in serpiginous pattern</li>
                                <li>Forms firm reddish-brown verrucous plaque</li>
                                <li>Center may become fluctuant with expressible pus and debris</li>
                                <li>May heal spontaneously after several years</li>
                            </ul>
                        </li>
                        <li>Tuberculin skin test: Positive </li>
                        <li>Histopathology:
                            <ul>
                                <li>Acute inflammation in epidermis</li>
                                <li>Pseudoepitheliomatous hyperplasia</li>
                                <li>Microabscesses in upper dermis</li>
                                <li>Sparse granulomatous foci</li>
                                <li>Bacilli often scant and difficult to find (paucibacillary)</li>
                            </ul>
                        </li>
                        <li>Diagnosis:
                            <ul>
                                <li>Culture to confirm M. tuberculosis</li>
                                <li>PCR for rapid identification</li>
                                <li>IGRA should be positive</li>
                                <li>Supportive histology</li>
                            </ul>
                        </li>
                        <li>Differential diagnosis:
                            <ul>
                                <li>Warts (common verrucae)</li>
                                <li>Verrucous fungal infections (chromomycosis)</li>
                                <li>Tertiary syphilis</li>
                                <li>Hypertrophic lichen planus</li>
                                <li>Verrucous carcinoma</li>
                            </ul>
                        </li>
                    </ul>
                </div>
            </div>
            
            <button class="collapsible">Tuberculous Chancre</button>
            <div class="content">
                <div class="content-inner">
                    <ul>
                        <li>Occurs in previously uninfected individuals <span class="highlight">without prior TB immunity</span></li>
                        <li>Clinical features:
                            <ul>
                                <li>Develops 2-4 weeks after inoculation</li>
                                <li>Begins as painless, firm, red-brown papulonodule</li>
                                <li>Slowly enlarges and erodes to form sharply demarcated ulcer</li>
                                <li>Regional lymphadenopathy </li>
                                <li>Typically heals spontaneously within 3-12 months with atrophic scar</li>
                            </ul>
                        </li>
                        <li>Histopathology:
                            <ul>
                                <li>Early: Acute neutrophilic inflammation with necrosis; bacilli present</li>
                                <li>Later: Granulomatous inflammation with caseation; bacilli disappear</li>
                            </ul>
                        </li>
                        <li>Tuberculin test: Initially negative</li>
                        <li>Rare, except in Asia (1-2% of cutaneous TB cases)</li>
                        <li>Diagnosis: History, culture, PCR for rapid identification</li>
                        <li>Differential diagnosis: Pyogenic ulcers, sporotrichosis, fungal infections, M. marinum, nocardiosis, tularemia, syphilis, cat scratch disease</li>
                    </ul>
                </div>
            </div>
            
            <button class="collapsible">Tuberculids</button>
            <div class="content">
                <div class="content-inner">
                    <p>- The tuberculids represent a group of disorders that classically were associated with systemic TB.</p>
                    <p>- They are considered immune reactions within the skin due to hematogenous dissemination of M. tuberculosis or its antigens from a primary source, in an individual with strong antituberculous cell-mediated immunity.</p>
                    <p>- Often beginning as an immune complex-mediated reaction, they evolve into a granulomatous inflammatory response.</p>
                    <ul>
                        <li><strong>Papulonecrotic tuberculid</strong>
                            <ul>
                                <li>Seen most frequently in children and young adults</li>
                                <li>Presents with dusky red papules or papulopustules that are widely distributed in a symmetric pattern</li>
                                <li>Typically favor the extensor extremities and buttocks</li>
                                <li>Individual lesions may have central necrosis and are usually asymptomatic</li>
                                <li>Histopathologically, there is associated vasculitis</li>
                                <li>Usually there is spontaneous healing of individual lesions, often with scar formation</li>
                                <li>Multiple cyclic eruptions are characteristic, even after antituberculous therapy</li>
                                <li>Due to PLEVA, GVHD</li>
                                <li><img src="images/pap.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                                <li><img src="images/pap1.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                            </ul>
                        </li>
                        <li><strong>Lichen scrofulosorum</strong>
                            <ul>
                                <li>The early lesions of lichen scrofulosorum are firm, typically perifollicular, tiny yellow-brown, tiny flat-topped papules with variable scaling</li>
                                <li>These asymptomatic papules are grouped in clusters, predominantly on the trunk</li>
                                <li>Lesions may persist for months and then disappear without scarring</li>
                                <li>Although it is seen in all age groups, children with active TB are most frequently affected</li>
                                <li>This type of tuberculid has been frequently reported after BCG vaccination and can be triggered by tuberculin testing in highly reactive patients</li>
                                <li><img src="images/idsc.jpg" style="max-width: 50%; border-radius: 3px; margin: 5px 0;"></li>
                            </ul>
                        </li>
                        <li><strong>Erythema induratum (nodular vasculitis)</strong>
                            <ul>
                                <li>A form of lobular panniculitis that is associated with M. tuberculosis infection in a subset of affected individuals, especially in countries with a high prevalence of TB</li>
                                <li>Both immune complex deposition, which may play a role in the vasculitic component, and a delayed-type hypersensitivity reaction to mycobacterial antigens are thought to be involved in the pathogenesis</li>
                                <li>Women are most commonly affected (80-90% of patients), with peaks in incidence during early adolescence and around menopause</li>
                                <li>Symptoms often begin after exposure to low temperatures</li>
                                <li>Typically, subcutaneous nodules appear on the posterior of both legs that may progress to deep, chronic, irregular deep ulcers with undermined borders</li>
                                <li>Healing results in atrophic, hyperpigmented scars</li>
                            </ul>
                        </li>
                    </ul>
                </div>
            </div>
            
            <h3>Diagnosis</h3>
            
            <div class="table-container">
                <table>
                    <tr>
                        <th>Diagnostic Method</th>
                        <th>Features</th>
                    </tr>
                    <tr>
                        <td><strong>Histopathology</strong></td>
                        <td>
                            <ul>
                                <li>Granulomatous inflammation (hallmark)</li>
                                <li>Caseation necrosis (variable)</li>
                                <li>Epithelioid histiocytes & Langhans giant cells</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><strong>AFB Stain</strong></td>
                        <td>
                            <ul>
                                <li>Often negative in paucibacillary forms (LV, tuberculids)</li>
                                <li>More likely positive in scrofuloderma, chancre</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Mantoux & IGRA</strong></td>
                        <td>
                            <ul>
                                <li>Strongly positive: Lupus vulgaris, Lichen scrofulosorum, Papulonecrotic tuberculid, Erythema induratum</li>
                                <li>Commonly positive: Tuberculosis verrucosa cutis</li>
                                <li>IGRA preferred in BCG-vaccinated individuals</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Culture</strong></td>
                        <td>
                            <ul>
                                <li><span class="highlight">Gold standard</span> for definitive diagnosis</li>
                                <li>Slow growing - inform lab to culture for Mycobacteria</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><strong>PCR</strong></td>
                        <td>
                            <ul>
                                <li>Rapid and sensitive</li>
                                <li>Useful when AFB/culture negative</li>
                                <li>Can be used on paraffin-embedded tissue</li>
                            </ul>
                        </td>
                    </tr>
                </table>
            </div>
            
            <h3>Treatment</h3>
            
            <div class="memory-box">
                <h4>üìå Standard Anti-TB Therapy (ATT)</h4>
                <p><strong>Intensive Phase (2 months):</strong> <span class="highlight">HRZE</span> - Isoniazid, Rifampin, Pyrazinamide, Ethambutol</p>
                <p><strong>Continuation Phase (4+ months):</strong> <span class="highlight">HR</span> - Isoniazid, Rifampin</p>
                <p>‚ö†Ô∏è Extended treatment (6-9 months) often needed for cutaneous TB</p>
            </div>
        </div>
        
        <!-- NTM TAB -->
        <div id="ntm" class="tab-content">
            <h2>Non-Tuberculous Mycobacteria (NTM)</h2>
            
            <div class="memory-box">
                <h4>üß† Common Species & Exposures</h4>
                <ul>
                    <li><strong>M. marinum</strong>: "Fish Tank Granuloma" - aquatic exposure</li>
                    <li><strong>M. ulcerans</strong>: "Buruli Ulcer" - endemic water exposure</li>
                    <li><strong>RGM</strong>: M. fortuitum, M. chelonae, M. abscessus - some has The ability survive sterilization procedures and to even contaminate antiseptic solutions can lead to infections in surgical patients.post-procedural, medical devices</li>
                </ul>
            </div>
            
            <h3>Clinical Presentations</h3>
            
            <div class="table-container">
                <table>
                    <tr>
                        <th>Species</th>
                        <th>Key Features</th>
                    </tr>
                    <tr>
                        <td><strong>M. marinum</strong></td>
                        <td>
                            <ul>
                                <li><span class="highlight">Sporotrichoid pattern</span> (ascending lesions along lymphatics)</li>
                                <li>Extremities (often hands)</li>
                                <li>Aquarium or swimming pool exposure</li>
                                <li>Grows best at 31¬∞C (slower than other mycobacteria)</li>
                                <li>Treatment: clarithromycin, rifampin/ethambutol, minocycline, or TMP-SMX</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><strong>M. ulcerans</strong></td>
                        <td>
                            <ul>
                                <li>Painless, deep, undermined ulcer</li>
                                <li>Starts as nodule</li>
                                <li><span class="highlight">Mycolactone toxin</span> causes tissue destruction</li>
                                <li>Endemic in Africa, Australia, Asia</li>
                                <li>Affects children &lt;15 years old</li>
                                <li>HIV-infected individuals do not appear to be predisposed</li>
                                <li>Ulcers on extremities; can become &gt;15 cm and extend to bones</li>
                                <li>Skin lesions are painless</li>
                                <li>No regional lymphadenopathy or systemic manifestations</li>
                                <li>Treatment: excision (treatment of choice), local heating, rifampin + streptomycin, and amputation</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><strong>M. avium complex</strong></td>
                        <td>
                            <ul>
                                <li>More commonly seen in AIDS patients</li>
                                <li>Found in environment (water, soil, animals)</li>
                                <li>Pulmonary infection is most common finding</li>
                                <li>Skin findings w/ primary inoculation or via dissemination (pustules, ulcers on legs, nodules)</li>
                                <li>‚Üëalkaline phosphatase with disseminated disease</li>
                                <li>Tx: clarithromycin/azithromycin + ethambutol +/- rifampin</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Rapid growing mycobacteria</strong><br>(M. fortuitum, M. chelonae, M. abscessus)</td>
                        <td>
                            <ul>
                                <li>Post-trauma or procedure history</li>
                                <li>Pustules, abscesses, nodules</li>
                                <li>Surgery, injection, tattoo sites</li>
                                <li>M. fortuitum in nail salon exposures</li>
                                <li>Rapid growing mycobacteria</li>
                                <li>Saprophytic organisms - lives on dead materials</li>
                                <li>Can get infections posttrauma/surgery or medical treatments (e.g., implant placement, liposuction, botulinum toxin)</li>
                                <li>Post-injection abscess is another frequent presentation</li>
                                <li>Skin presentations vary, but most common is inflamed subcutaneous nodules</li>
                                <li>Grows on routine bacterial culture media (5% sheep blood agar or chocolate agar) within 7 days</li>
                                <li>Consider in patients with therapy-resistant or "cold" abscesses</li>
                                <li>Clarithromycin is treatment of choice, but surgical treatment may be needed</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><strong>M. scrofulaceum</strong></td>
                        <td>
                            <ul>
                                <li>Produces <span class="highlight">self-limited disease</span>, particularly lymphadenitis</li>
                                <li>May cause <span class="highlight">cervical lymphadenitis with sinus formation</span> clinically <span class="highlight">indistinguishable from scrofuloderma</span></li>
                                <li>Widely distributed in environment - found in dairy products, <span class="highlight">oysters</span>, soil, and water</li>
                                <li>Found on the skin of healthy people and in cutaneous lesions of leprosy</li>
                                <li>Primarily affects children via inhalation or ingestion</li>
                                <li>May cause pulmonary disease and local lymphadenitis, primarily in submandibular and submaxillary regions</li>
                                <li><span class="highlight">Usually a benign, self-limited condition with no systemic symptoms except for mild neck pain</span></li>
                                <li>Involved lymph nodes slowly enlarge over several weeks, eventually leading to ulceration and drainage with fistula formation</li>
                                <li>Can also produce cutaneous lesions in a <span class="highlight">sporotrichoid pattern</span></li>
                                <li>Tx: <span class="highlight">Total excision of the involved lymph nodes</span> is treatment of choice because, in general, antibiotic therapy is unsatisfactory</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><strong>M. haemophilum</strong></td>
                        <td>
                            <ul>
                                <li>Fastidious organism that <span class="highlight">requires ferric ions to grow</span></li>
                                <li>Requires hemin, hematin, hemoglobin, or ferric ammonium citrate</li>
                                <li>Primarily affects <span class="highlight">immunocompromised hosts</span></li>
                                <li>Patients treated with <span class="highlight">TNF inhibitors are at increased risk</span></li>
                                <li>Can cause cervical lymphadenitis in healthy children</li>
                                <li>Cutaneous infections following tattooing (including permanent make-up) and acupuncture</li>
                                <li>Presents as <span class="highlight">single bluish-red tender pustule, papulonodule, or plaque</span></li>
                                <li>Evolves into an <span class="highlight">abscess and/or ulcer</span></li>
                                <li>Lesions often multiple and located on the extremities, often overlying joints</li>
                                <li>Requires a special environment to grow, with a <span class="highlight">temperature between 30¬∞C and 32¬∞C</span></li>
                                <li>Tx: rifampin and clarithromycin</li>
                            </ul>
                        </td>
                    </tr>
                </table>
            </div>
            
            <h3>Diagnosis</h3>
            
            <ul>
                <li>Consider NTM in non-healing granulomatous lesions with relevant exposure</li>
                <li>Histopathology: Granulomas, neutrophilic abscesses with RGM</li>
                <li>AFB Stain: Often positive, but not always</li>
                <li><span class="highlight">Culture on specialized media</span>: Essential for species ID and susceptibility</li>
                <li>Important: Inform lab you suspect NTM! Different growth requirements</li>
                <li>PCR & 16S rRNA Sequencing: Rapid identification</li>
            </ul>
            
            <h3>Treatment</h3>
            
            <div class="memory-box">
                <h4>üìå Macrolide-Based Regimens</h4>
                <p><strong>Foundation:</strong> Clarithromycin or Azithromycin</p>
                <p><strong>Combination with:</strong></p>
                <ul>
                    <li>Rifabutin, Ethambutol</li>
                    <li>Quinolones (Moxifloxacin, Ciprofloxacin)</li>
                    <li>Amikacin, Linezolid, Doxycycline, TMP-SMX</li>
                </ul>
                <p><strong>Other considerations:</strong></p>
                <ul>
                    <li>Surgical excision for localized lesions</li>
                    <li>Prolonged treatment (3-6+ months)</li>
                    <li>Susceptibility testing essential for RGM</li>
                </ul>
            </div>
        </div>
        
        <!-- TB DRUGS TAB -->
        <div id="tb-drugs" class="tab-content">
            <h2>Anti-Tuberculosis Drug Side Effects</h2>
            
            <div class="memory-box">
                <h4>üß† First-Line TB Drugs: HRZE</h4>
                <ul>
                    <li><strong>H</strong>: Isoniazid (INH)</li>
                    <li><strong>R</strong>: Rifampin (RIF)</li>
                    <li><strong>Z</strong>: Pyrazinamide (PZA)</li>
                    <li><strong>E</strong>: Ethambutol (EMB)</li>
                </ul>
            </div>
            
            <h3>Key Side Effects by Drug</h3>
            
            <div class="table-container">
                <table class="drug-table">
                    <tr>
                        <th>Drug</th>
                        <th>Dermatologic</th>
                        <th>Systemic</th>
                        <th>Monitoring</th>
                    </tr>
                    <tr>
                        <td><strong>Isoniazid (INH)</strong></td>
                        <td>
                            <ul>
                                <li>Rash</li>
                                <li>SJS/TEN (rare)</li>
                            </ul>
                        </td>
                        <td>
                            <ul>
                                <li><span class="highlight">Peripheral Neuropathy</span></li>
                                <li>Hepatotoxicity</li>
                            </ul>
                        </td>
                        <td>
                            <ul>
                                <li>LFTs</li>
                                <li>Neurological exam</li>
                                <li>Prevent neuropathy with Vitamin B6 (Pyridoxine)</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Rifampin (RIF)</strong></td>
                        <td>
                            <ul>
                                <li>Rash</li>
                                <li><span class="highlight">Orange discoloration</span> of secretions</li>
                            </ul>
                        </td>
                        <td>
                            <ul>
                                <li>Hepatotoxicity</li>
                                <li>Hepatic enzyme induction</li>
                                <li>Drug interactions</li>
                            </ul>
                        </td>
                        <td>
                            <ul>
                                <li>LFTs</li>
                                <li>Warn patients about orange secretions</li>
                                <li>Check drug interactions</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Pyrazinamide (PZA)</strong></td>
                        <td>
                            <ul>
                                <li><span class="highlight">Photosensitivity</span></li>
                                <li>Rash</li>
                            </ul>
                        </td>
                        <td>
                            <ul>
                                <li>Hyperuricemia (gout)</li>
                                <li>Hepatotoxicity</li>
                            </ul>
                        </td>
                        <td>
                            <ul>
                                <li>LFTs</li>
                                <li>Uric acid (if gout history)</li>
                                <li>Sun protection</li>
                            </ul>
                        </td>
                    </tr>
                    <tr>
                        <td><strong>Ethambutol (EMB)</strong></td>
                        <td>
                            <ul>
                                <li>Rash</li>
                            </ul>
                        </td>
                        <td>
                            <ul>
                                <li><span class="highlight">Optic Neuritis</span></li>
                                <li>Color blindness (red-green)</li>
                                <li>Decreased visual acuity</li>
                            </ul>
                        </td>
                        <td>
                            <ul>
                                <li>Regular vision testing</li>
                                <li>Color vision testing</li>
                                <li>Stop if vision changes</li>
                            </ul>
                        </td>
                    </tr>
                </table>
            </div>
            
            <h3>Managing Drug Side Effects</h3>
            
            <div class="card-container">
                <div class="card" style="width: 100%;">
                    <div class="card-header drug-header">Drug-Induced Hepatitis</div>
                    <div class="card-body">
                        <p><strong>Symptoms:</strong> RUQ pain, nausea, vomiting, jaundice, fatigue</p>
                        <p><strong>Labs:</strong> Elevated LFTs (AST, ALT, bilirubin)</p>
                        <p><strong>Management:</strong></p>
                        <ol>
                            <li>Stop all hepatotoxic drugs</li>
                            <li>After LFTs normalize, reintroduce one by one:</li>
                            <ol type="a">
                                <li>Start with Rifampin</li>
                                <li>Then add INH</li>
                                <li>Then add Ethambutol</li>
                                <li>PZA often avoided if severe hepatitis</li>
                            </ol>
                        </ol>
                    </div>
                </div>
            </div>
            
            <div class="memory-box">
                <h4>‚ö†Ô∏è Serious Reactions Requiring Immediate Drug Discontinuation</h4>
                <ul>
                    <li>SJS/TEN</li>
                    <li>Severe hepatitis</li>
                    <li>Optic neuritis</li>
                    <li>Severe neuropathy</li>
                </ul>
                <p>Always consult ID/Pulm specialist for management!</p>
            </div>
        </div>
    </div>

    <script>
        // Tab functionality
        function openTab(evt, tabName) {
            var i, tabContent, tabBtns;
            
            tabContent = document.getElementsByClassName("tab-content");
            for (i = 0; i < tabContent.length; i++) {
                tabContent[i].classList.remove("active");
            }
            
            tabBtns = document.getElementsByClassName("tab-btn");
            for (i = 0; i < tabBtns.length; i++) {
                tabBtns[i].classList.remove("active");
            }
            
            document.getElementById(tabName).classList.add("active");
            evt.currentTarget.classList.add("active");
        }
        
        // Collapsible content
        var coll = document.getElementsByClassName("collapsible");
        for (var i = 0; i < coll.length; i++) {
            coll[i].addEventListener("click", function() {
                this.classList.toggle("active");
                var content = this.nextElementSibling;
                if (content.style.maxHeight) {
                    content.style.maxHeight = null;
                } else {
                    content.style.maxHeight = content.scrollHeight + "px";
                }
            });
        }
        
        // Search functionality
        document.addEventListener('DOMContentLoaded', function() {
            const searchInput = document.getElementById('searchInput');
            const searchButton = document.getElementById('searchButton');
            const searchResults = document.getElementById('searchResults');
            const resultsList = document.getElementById('resultsList');
            const resultCount = document.getElementById('resultCount');
            const closeResults = document.getElementById('closeResults');
            
            // Add Font Awesome for icons
            const fontAwesome = document.createElement('link');
            fontAwesome.rel = 'stylesheet';
            fontAwesome.href = 'https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.4/css/all.min.css';
            document.head.appendChild(fontAwesome);
            
            // Function to perform search
            function performSearch() {
                const searchTerm = searchInput.value.trim().toLowerCase();
                if (searchTerm.length < 2) return; // Require at least 2 characters
                
                // Clear previous results
                resultsList.innerHTML = '';
                
                let results = [];
                let resultSections = new Set();
                
                // Search in all collapsible content and their preceding headers
                const collapsibles = document.getElementsByClassName('collapsible');
                for (let i = 0; i < collapsibles.length; i++) {
                    const header = collapsibles[i];
                    const content = header.nextElementSibling;
                    const headerText = header.textContent.toLowerCase();
                    const contentText = content.textContent.toLowerCase();
                    
                    // Check if search term exists in header or content
                    if (headerText.includes(searchTerm) || contentText.includes(searchTerm)) {
                        resultSections.add(header);
                        
                        // Get tab content this collapsible belongs to
                        const tabContent = header.closest('.tab-content');
                        const tabId = tabContent.id;
                        const tabName = document.querySelector(`.tab-btn[onclick*="${tabId}"]`).textContent;
                        
                        // Create result object
                        let resultText = contentText.includes(searchTerm) ? contentText : headerText;
                        let startIndex = resultText.indexOf(searchTerm);
                        // Get context around the match (50 characters before and after)
                        let startContext = Math.max(0, startIndex - 50);
                        let endContext = Math.min(resultText.length, startIndex + searchTerm.length + 50);
                        let context = '...' + resultText.substring(startContext, endContext) + '...';
                        
                        results.push({
                            header: header,
                            content: content,
                            tabId: tabId,
                            tabName: tabName,
                            title: headerText,
                            context: context,
                            index: startIndex
                        });
                    }
                }
                
                // Also search in table cells
                const tableCells = document.querySelectorAll('td, th');
                for (let i = 0; i < tableCells.length; i++) {
                   const cell = tableCells[i];
                    const cellText = cell.textContent.toLowerCase();
                    
                    if (cellText.includes(searchTerm)) {
                        // Get the table and find its parent section
                        const table = cell.closest('table');
                        const tabContent = table.closest('.tab-content');
                        const tabId = tabContent.id;
                        const tabName = document.querySelector(`.tab-btn[onclick*="${tabId}"]`).textContent;
                        
                        // Try to find a header near this table
                        let header = null;
                        let prevElement = table.previousElementSibling;
                        while (prevElement && !header) {
                            if (prevElement.tagName === 'H3' || prevElement.tagName === 'H2') {
                                header = prevElement;
                            }
                            prevElement = prevElement.previousElementSibling;
                        }
                        
                        let headerText = header ? header.textContent : 'Table';
                        
                        let startIndex = cellText.indexOf(searchTerm);
                        let startContext = Math.max(0, startIndex - 50);
                        let endContext = Math.min(cellText.length, startIndex + searchTerm.length + 50);
                        let context = '...' + cellText.substring(startContext, endContext) + '...';
                        
                        results.push({
                            element: cell,
                            tabId: tabId,
                            tabName: tabName,
                            title: headerText,
                            context: context,
                            index: startIndex
                        });
                    }
                }
                
                // Display results count
                resultCount.textContent = `${results.length} results found`;
                
                // Sort results by tab and then by position in document
                results.sort((a, b) => {
                    if (a.tabId !== b.tabId) {
                        return a.tabId.localeCompare(b.tabId);
                    }
                    return a.index - b.index;
                });
                
                // Add results to the list
                let currentTab = '';
                
                results.forEach((result, index) => {
                    // Add tab header if it's a new tab
                    if (currentTab !== result.tabId) {
                        currentTab = result.tabId;
                        const tabHeader = document.createElement('div');
                        tabHeader.className = 'result-tab-header';
                        tabHeader.textContent = result.tabName;
                        tabHeader.style.padding = '5px 10px';
                        tabHeader.style.background = '#f0f0f0';
                        tabHeader.style.fontWeight = 'bold';
                        tabHeader.style.borderBottom = '1px solid #ddd';
                        resultsList.appendChild(tabHeader);
                    }
                    
                    // Create result item
                    const resultItem = document.createElement('div');
                    resultItem.className = 'result-item';
                    
                    // Create title element
                    const title = document.createElement('h4');
                    title.textContent = result.title.charAt(0).toUpperCase() + result.title.slice(1);
                    resultItem.appendChild(title);
                    
                    // Create context with highlighted term
                    const context = document.createElement('div');
                    context.className = 'result-context';
                    const highlightedContext = result.context.replace(
                        new RegExp(searchTerm, 'gi'), 
                        match => `<span class="search-highlight">${match}</span>`
                    );
                    context.innerHTML = highlightedContext;
                    resultItem.appendChild(context);
                    
                    // Add click event to navigate to the result
                    resultItem.addEventListener('click', function() {
                        // Switch to the correct tab
                        document.querySelector(`.tab-btn[onclick*="${result.tabId}"]`).click();
                        
                        // If it's a collapsible section, expand it
                        if (result.header && result.header.classList.contains('collapsible')) {
                            if (!result.header.classList.contains('active')) {
                                result.header.click();
                            }
                        }
                        
                        // Scroll to the element
                        const elementToScroll = result.element || result.header || result.content;
                        elementToScroll.scrollIntoView({ behavior: 'smooth', block: 'center' });
                        
                        // Highlight the search term in the actual content
                        highlightSearchTerm(searchTerm);
                        
                        // Close the results panel
                        searchResults.style.display = 'none';
                    });
                    
                    resultsList.appendChild(resultItem);
                });
                
                // Show results container
                searchResults.style.display = 'block';
            }
            
            // Function to highlight search term in the actual content
            function highlightSearchTerm(term) {
                // Remove any existing highlights
                const existingHighlights = document.querySelectorAll('.content-highlight');
                existingHighlights.forEach(el => {
                    const parent = el.parentNode;
                    parent.replaceChild(document.createTextNode(el.textContent), el);
                    parent.normalize();
                });
                
                // Create a recursive function to traverse text nodes
                function highlightTextNodes(node) {
                    if (node.nodeType === 3) { // Text node
                        const text = node.nodeValue;
                        const regex = new RegExp(term, 'gi');
                        if (regex.test(text)) {
                            const fragment = document.createDocumentFragment();
                            let lastIndex = 0;
                            let match;
                            const pattern = new RegExp(term, 'gi');
                            
                            while ((match = pattern.exec(text)) !== null) {
                                // Add text before the match
                                if (match.index > lastIndex) {
                                    fragment.appendChild(document.createTextNode(text.substring(lastIndex, match.index)));
                                }
                                
                                // Create highlighted span for the match
                                const highlighted = document.createElement('span');
                                highlighted.className = 'search-highlight content-highlight';
                                highlighted.appendChild(document.createTextNode(match[0]));
                                fragment.appendChild(highlighted);
                                
                                lastIndex = pattern.lastIndex;
                            }
                            
                            // Add any remaining text
                            if (lastIndex < text.length) {
                                fragment.appendChild(document.createTextNode(text.substring(lastIndex)));
                            }
                            
                            // Replace original node with the fragment
                            node.parentNode.replaceChild(fragment, node);
                            return true;
                        }
                    } else if (node.nodeType === 1) { // Element node
                        // Skip script and style elements
                        if (node.tagName === 'SCRIPT' || node.tagName === 'STYLE') {
                            return false;
                        }
                        
                        // Process child nodes
                        Array.from(node.childNodes).forEach(child => {
                            highlightTextNodes(child);
                        });
                    }
                    return false;
                }
                
                // Start highlighting from the body
                highlightTextNodes(document.body);
            }
            
            // Event listeners
            searchButton.addEventListener('click', performSearch);
            
            searchInput.addEventListener('keyup', function(event) {
                if (event.key === 'Enter') {
                    performSearch();
                }
            });
            
            closeResults.addEventListener('click', function() {
                searchResults.style.display = 'none';
            });
            
            // Close results when clicking outside
            document.addEventListener('click', function(event) {
                if (!searchResults.contains(event.target) && 
                    event.target !== searchInput && 
                    event.target !== searchButton) {
                    searchResults.style.display = 'none';
                }
            });
        });
    </script>
</body>
</html>



